|
1
|
Lee MS, Hsu CC, Wahlqvist ML, Tsai HN,
Chang YH and Huang YC: Type 2 diabetes increases and metformin
reduces total, colorectal, liver and pancreatic cancer incidences
in Taiwanese: A representative population prospective cohort study
of 800,000 individuals. BMC Cancer. 11:202011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH
and Kim WH: The effects of metformin on the survival of colorectal
cancer patients with diabetes mellitus. Int J Cancer. 131:752–759.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang N, Docherty F, Brown HK, Reeves K,
Fowles A, Lawson M, Ottewell PD, Holen I, Croucher PI and Eaton CL:
Mitotic quiescence, but not unique ‘stemness,’ marks the phenotype
of bone metastasis-initiating cells in prostate cancer. FASEB J.
29:3141–3150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mukherjee S, Manna A, Bhattacharjee P,
Mazumdar M, Saha S, Chakraborty S, Guha D, Adhikary A, Jana D,
Gorain M, et al: Non-migratory tumorigenic intrinsic cancer stem
cells ensure breast cancer metastasis by generation of CXCR4(+)
migrating cancer stem cells. Oncogene. 35:4937–4948. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saha S, Mukherjee S, Khan P, Kajal K,
Mazumdar M, Manna A, Mukherjee S, De S, Jana D, Sarkar DK and Das
T: Aspirin suppresses the acquisition of chemoresistance in breast
cancer by disrupting an NFκB-IL6 signaling axis responsible for the
generation of cancer stem cells. Cancer Res. 76:2000–2012. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suwei D, Liang Z, Zhimin L, Ruilei L,
Yingying Z, Zhen L, Chunlei G, Zhangchao L, Yuanbo X, Jinyan Y, et
al: NLK functions to maintain proliferation and stemness of NSCLC
and is a target of metformin. J Hematol Oncol. 8:1202015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yuan X, Wei W, Bao Q, Chen H, Jin P and
Jiang W: Metformin inhibits glioma cells stemness and
epithelial-mesenchymal transition via regulating YAP activity.
Biomed Pharmacother. 102:263–270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Wang H, Li C, Zhao Y, Wu L, Du X
and Han Z: VEGF-A/neuropilin 1 pathway confers cancer stemness via
activating Wnt/β-catenin axis in breast cancer cells. Cell Physiol
Biochem. 44:1251–1262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang K, Guo Y, Wang X, Zhao H, Ji Z,
Cheng C, Li L, Fang Y, Xu D, Zhu HH and Gao WQ: WNT/β-catenin
directs self-renewal symmetric cell division of
hTERThigh prostate cancer stem cells. Cancer Res.
77:2534–2547. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garikapati KR, Patel N, Makani VKK,
Cilamkoti P, Bhadra U and Bhadra MP: Down-regulation of BORIS/CTCFL
efficiently regulates cancer stemness and metastasis in MYCN
amplified neuroblastoma cell line by modulating Wnt/β-catenin
signaling pathway. Biochem Biophys Res Commun. 484:93–99. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kida K, Ishikawa T, Yamada A, Shimada K,
Narui K, Sugae S, Shimizu D, Tanabe M, Sasaki T, Ichikawa Y and
Endo I: Effect of ALDH1 on prognosis and chemoresistance by breast
cancer subtype. Breast Cancer Res Treat. 156:261–269. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ren D, Zhu X, Kong R, Zhao Z, Sheng J,
Wang J, Xu X, Liu J, Cui K, Zhang XH, et al: Targeting
brain-adaptive cancer stem cells prohibits brain metastatic
colonization of triple-negative breast cancer. Cancer Res.
78:2052–2064. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu S, Yang Z, Jin P, Yang X, Li X, Wei X,
Wang Y, Long S, Zhang T, Chen G, et al: Metformin suppresses tumor
progression by inactivating stromal fibroblasts in ovarian cancer.
Mol Cancer Ther. 17:1291–1302. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee JE, Lim JH, Hong YK and Yang SH:
High-dose metformin plus temozolomide shows increased anti-tumor
effects in glioblastoma in vitro and in vivo compared with
monotherapy. Cancer Res Treat. 50:1331–1342. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tian Y, Tang B, Wang C, Sun D, Zhang R,
Luo N, Han Z, Liang R, Gao Z and Wang L: Metformin mediates
resensitivity to 5-fluorouracil in hepatocellular carcinoma via the
suppression of YAP. Oncotarget. 7:46230–46241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng G and Lanza-Jacoby S: Metformin
decreases growth of pancreatic cancer cells by decreasing reactive
oxygen species: Role of NOX4. Biochem Biophys Res Commun.
465:41–46. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, He C and Huang X: Metformin
partially reverses the carboplatin-resistance in NSCLC by
inhibiting glucose metabolism. Oncotarget. 8:75206–75216.
2017.PubMed/NCBI
|
